United States-based Myriad Genetics, the world’s largest molecular diagnostic company, announced a strategic partnership with Positive Bioscience to offer the first-of-its-kind molecular genomic testing in India, says a press release.

With the rapid advancement in genomics and testing technologies, clinicians are able to diagnose cancer more precisely and advise their patients about the need for screening or treatment in order to save and improve patient’s lives.

Genomic testing is still at an early stage in India and this partnership could revolutionize genomics testing in this country.

These tests will help screen for cancer risks and enable families of cancer patients to take various preventive measures. All testing will be carried out at Myriad’s high quality labs in USA and Germany.